OncoLink at ASTRO 2000: Monday, October 23 | Oncolink

Oncolink Features

Find My Cancer Drug

A Phase II Randomized Trial of Synchronous Radiotherapy With Temozolomide in Brain Metastases Presenter: E. Paraskevaidis Affiliation: Metaxas Cancer Hospital, Pireus, Greece Summary: The majority of patients with brain metastases has a dismal survival of approximately 4 months. Various strategies have been investigated, ...
Health Policy Expert Marc Roberts, PhD, Urges Physicians to Be on the Front Lines of Change in the Health Care System Inevitable changes in how services are paid for in our current health care system require physicians to take the initiative to get involved, said Marc Roberts, Harvard University Professor of Political Economy and Health Policy, during this...
Impact of a boost dose of 16 Gy on the local control and cosmesis in patients with early breast cancer: The EORTC boost versus no boost trial Presenter: H. Bartelink Affiliation: The Netherlands Cancer Institute Summary: Breast conservation therapy (BCT) is a standard of care in the management of patients with early stage breast cancers. BCT results have consistently...
Intergroup 0116 (SWOG 9008)- phase III trial of postoperative adjuvant radiochemotherapy for high risk gastric and gastroesophageal junction adenocarcinoma: Evaluation of efficacy and radiotherapy treatment planning Presenter: S. Smalley Affiliation: Intergroup/SWOG Background: The management of patients with locally advanced gastric adenocarcinoma (ACA) remains a major challenge for oncologists. Complete surgical resection has been the...
Neuropsychological effects of fractionated, stereotactic radiation therapy (FSRT) in patients with meningiomas Presenter: G. Welzel Affiliation: University of Heidelberg Summary: Meningiomas are benign, slow growing tumors with a good survival rate after radiotherapy. Neurotoxicity after irradiation of the central nervous system is widely...
Panel Presentation Examines the Use of Unconventional Medical Therapies by Cancer Patients Some recent scientific studies, combined with anecdotal evidence from doctors and nurses, suggest that many cancer patients are using so-called "unconventional medical therapies" while they are undergoing radiation, chemotherapy, or other...
Preliminary Report of RTOG 9508: A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with Two or Three Unresected Brain Metastases Presenter: P. W. Sperduto Affiliation: Radiation Therapy Oncology Group Summary: Brain metastases develop in approximately 25% of all cancer patients. Management with stereotactic radiotherapy for patients with 3 or less solitary lesions...
Randomized Treatment of Brain Metastasis with Gamma Knife Radiosurgery, Whole Brain Radiotherapy or Both Presenter: P. B. Chougule Affiliation Rhode Island Hospital/Brown University, Providence, RI Summary: Brain metastases develop in approximately 25% of all cancer patients. Management with whole brain RT may palliated these patients, but...
Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both Presenter: P.B. Chougule Affiliation: Rhode Island Hospital, Brown University Summary: Whole brain radiation therapy (WBRT) has been the standard care for the majority of patients with brain metastasis. However, the outcome of...
RTOG Protocol 92-02: A phase II trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate Presenter: Gerald E. Hanks Affiliation: RTOG Background: Controversy exists on the integration of hormonal therapy for the treatment of locally advanced prostate cancer. This trial was designed to determine if long term androgen ...
Sequential Vs. Concurrent Chemotherapy and Radiation Therapy for Inoperable Non-Small Cell Lung Cancer (NSCLC) Analysis of Failures in a Phase III Study (RTOG 9410) Presenter: R. Komaki, MD Affiliation: University of Texas MD Anderson Cancer Center Summary: Since the randomized trial reported by Dillman et al., the standard of care for the treatment of unresectable or inoperable non small ...
Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial Presenter: J. Bourhis, et al. Affiliation: Institut Gustave Roussy, Villejuif, France Summary: Squamous cell carcinomas of the head & neck are considered to be fairly rapid growing tumors. Advanced tumors are frequently ...